Autonomous AI systems are rapidly making their way into the health care system, presenting regulators with thorny questions about how to protect data, prevent
Tag - STAT Plus
Disarm Therapeutics, a Cambridge biotechnology firm working on new potential drugs for neurological diseases such as ALS and multiple sclerosis, will be bought
The heart needs a steady supply of oxygen and nutrients to keep beating — but the type of nutrients it relies on most depends on how healthy the heart is
Over the past few years, a pack of sleek, marketing-savvy startups have sprouted up offering online prescriptions for drugs for common medical conditions. But
Over more than two decades, the Food and Drug Administration approved opioid painkillers based on relatively brief pivotal clinical trials that relied on
A mandated safety program regulators rely on to minimize opioid abuse and misuse is not “well suited” to quickly address the ongoing crisis across the U.S. And
A U.S. appeals court upheld a controversial New York state law to require drug makers and distributors to fund a program for covering costs for treatment
Casma Therapeutics, a Cambridge biotech trying to develop new medicines based on discoveries about how cells detoxify and repair themselves, has raised $50
Amarin failed to convince a federal appeals court to revive key patents covering its heart drug Vascepa. The decision, announced Thursday, exposes the
Joining the ranks of other health tech giants, Amazon on Thursday debuted a wrist wearable that could give it a toehold into the increasingly hot field of
